Six Years Follow-Up of an 11-Year-Old Girl with Anti-HMGCR Myopathy

Creative Commons License

Cavusoglu D., TALİM B., Ekinci G., Topaloglu H.

JOURNAL OF NEUROMUSCULAR DISEASES, sa.4, ss.883-887, 2024 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Basım Tarihi: 2024
  • Doi Numarası: 10.3233/jnd-240022
  • Dergi Adı: JOURNAL OF NEUROMUSCULAR DISEASES
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, MEDLINE
  • Sayfa Sayıları: ss.883-887
  • Hacettepe Üniversitesi Adresli: Evet

Özet

. Anti-HMGCR myopathy is decribed as an immune-mediated necrotizing myopathy which is characterised by subacute, progressive proximal muscle weakness and elevated creatine kinase (CK) level. In pediatric population, antiHMGCR myopathy has been reported solely as small case reports, albeit rare. Although treatment consensus has not yet been established, proper treatment with several immunomodulators to include IVIg can show remarkable improvement. We report an 11-year-old-girl diagnosed with anti-HMGCR myopathy with 6 years of follow-up.